Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Charles Hennemeyer"'
Publikováno v:
Case Reports in Hepatology, Vol 2016 (2016)
Chronic Budd-Chiari syndrome can present with cirrhosis and signs and symptoms similar to those of other chronic liver diseases. We present a case of Budd-Chiari syndrome discovered during attempted transjugular intrahepatic portosystemic shunting in
Externí odkaz:
https://doaj.org/article/162c3396789f4c8b85da50df1480b541
Autor:
Igor Puzanov, Adi Diab, Peter M. Anderson, Srinivas Chunduru, Charles Hennemeyer, Gregory Woodhead, Nadia Kaplan, Rolf Hultsch, Ravi Murthy, Chantale Bernatchez, Daruka Mahadevan, Cara Haymaker, Hans Minderman, Shah Rahimian, Daniel Hendler, Corinne Maurice-Dror, Michael Lotem, Jacob Schachter, Alain Algazi, Sanjiv Agarwala, Vivek Subbiah, Erkut Borazanci, Hani Babiker
Supplementary Data from Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b20011d177d7d5a761e08f4d3ceb10
https://doi.org/10.1158/1078-0432.22488717.v1
https://doi.org/10.1158/1078-0432.22488717.v1
Autor:
Igor Puzanov, Adi Diab, Peter M. Anderson, Srinivas Chunduru, Charles Hennemeyer, Gregory Woodhead, Nadia Kaplan, Rolf Hultsch, Ravi Murthy, Chantale Bernatchez, Daruka Mahadevan, Cara Haymaker, Hans Minderman, Shah Rahimian, Daniel Hendler, Corinne Maurice-Dror, Michael Lotem, Jacob Schachter, Alain Algazi, Sanjiv Agarwala, Vivek Subbiah, Erkut Borazanci, Hani Babiker
Purpose:Tilsotolimod is an investigational synthetic Toll-like receptor 9 (TLR9) agonist that has demonstrated antitumor activity in preclinical models. The ILLUMINATE-101 phase I study explored the safety, dose, efficacy, and immune effects of intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd4ae721270634e26b1f77adf977a48
https://doi.org/10.1158/1078-0432.c.6532797
https://doi.org/10.1158/1078-0432.c.6532797
Autor:
Phillip H. Kuo, Mikin V. Patel, Lucas Struycken, Gregory Woodhead, H. McGregor, Charles Hennemeyer
Publikováno v:
American Journal of Roentgenology. 218:728-737
Background: Accurate assessment of hepatopulmonary shunting, typically performed by planar scintigraphy, is critical in planning yttrium-90 radioembolization. High lung shunt fractions (LSFs) may alter treatment. Objective: To compare LSFs calculated
Autor:
Paola Devis, Keneeshia N. Williams, Bellal Joseph, Mohamad Chehab, Nathan Sherman, Charles Hennemeyer, Andrew Tang
Publikováno v:
Journal of Trauma and Acute Care Surgery. 91:318-324
BACKGROUND Pelvic angioembolization (AE) is a mainstay in the treatment algorithm for pelvic hemorrhage from pelvic fractures. Nonselective AE refers to embolization of the bilateral internal iliac arteries (IIAs) proximally rather than embolization
Publikováno v:
The American Journal of Medicine. 134:326-331
Management of high-risk surgical patients with cholecystitis poses a significant clinical problem. These patients are often left with the options of permanent cholecystostomy tube drainage or high-risk surgery. Numerous attempts have been made over t
Autor:
Gregory Woodhead, H. McGregor, Mikin V. Patel, A. Khan, Charles Hennemeyer, Christopher Brunson
Publikováno v:
Journal of Vascular and Interventional Radiology. 32:198-203
Purpose To determine the hemodynamic effects of intra-arterial nitroglycerin on hepatocellular carcinoma (HCC) using 2-dimensional (2D) perfusion angiography. Materials and Methods Two-dimensional perfusion angiograms obtained prior to radioembolizat
Publikováno v:
Journal of Vascular and Interventional Radiology. 31:2156-2159
Publikováno v:
Journal of Vascular and Interventional Radiology. 31:512-515
Autor:
Abdul Sami Khan, Michael Robert Kendall, Lawrence Matiski, Charles Hennemeyer, Gregory Woodhead
Publikováno v:
JACC: Cardiovascular Interventions. 16:S58